| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Laboratoire de Physiopathologie de la Nutrition, CNRS URA 307, Université Paris VII (N.A., M.-C.L., J.-M.N., A.K., L.P.), Paris; and Laboratoire de Neurobiologie, Plasticité Tissulaire et Métabolisme Energétique, UPRESA 5018 Université Paul Sabatier-CNRS, IFR Louis Bugnard, CHU Rangueil (L.P.), Toulouse, France; and Laboratoire des Régulations Physiologiques, Faculté des Sciences Ibn Tofail (N.A., N.M.), Kenitra, Maroc
Address all correspondence and requests for reprints: Dr. L. Pénicaud, Laboratoire de Neurobiologie, Plasticité Tissulaire et Métabolisme Energétique, UPRESA 5018 Université Paul Sabatier-CNRS, 1 avenue Jean Poulhés 31054 Toulouse Cedex, France. E-mail: penicaud{at}rangueil.inserm.fr
| Abstract |
|---|
|
|
|---|
2-adrenoceptor agonist clonidine,
the insulin response to the intracarotid glucose load was totally
blunted in the two groups of rats. By contrast, whereas such a
pretreatment lowered the glucose-induced increase in islet blood flow
in C rats, it was without effect in HG rats. These data suggest that a
period of hyperglycemia and/or hyperinsulinemia is sufficient to induce
a perturbation of pancreatic islet blood flow, which appears to be
mainly due to an increased parasympathetic activity, whereas the
decrease in sympathetic tone does not play a role. These modifications
in autonomic nervous system activity could be due to alterations in
some brain areas involved in "glucose sensing." | Introduction |
|---|
|
|
|---|
On the other hand, although a direct effect of islet blood flow on insulin secretion has not yet been clearly demonstrated, islet blood flow could be involved in the control of plasma insulin kinetics by modulating the amount of nutrients reaching the islets and/or the dispersion of insulin into the blood (4, 5). Indeed, numerous studies have demonstrated that, in normal rats, glucose increased both plasma insulin levels and islet blood flow (5, 6). This effect of glucose appears to be mediated via the central and autonomic nervous systems (4, 7). This idea has been reinforced by data obtained in the obese Zucker rat (5, 8), in which high parasympathetic and low sympathetic tones were paralleled by increased islet blood flow and hyperinsulinemia (9, 10, 11).
We postulated that one of the mechanisms by which the autonomic nervous system could influence insulin secretion in rats submitted to a 48-h glucose infusion could be the alteration of islet blood flow.
The aim of the present work was thus to determine 1) whether islet blood flow was modified in hyperglycemic rats either under basal conditions or after an iv glucose load, and 2) the extent to which the possible changes in islet blood flow were under the influence of the modifications of the nervous system activity previously described in these rats.
| Materials and Methods |
|---|
|
|
|---|
Blood flow measurements
Blood flow measurements were performed 24 h after the end
of glucose infusion. Rats were anesthetized with sodium pentobarbital
(50 mg/kg, ip) and heparinized with an iv injection of 200 IU heparin
(Roche, Neuilly, France). This time was chosen after preliminary
experiments showed that 1) determination of the number of microspheres
was not easy 3 h after the end of glucose infusion due to the
edematous aspect of the pancreas; and 2) the insulin secretory response
to glucose was identically increased in HG rats both 3 and 24 h
after the end of glucose infusion (13).
Polyethylene catheters were placed into the lower abdominal aorta to measure arterial blood pressure and into the left ventricle of the heart via the right carotid artery for blood sampling. Body temperature was recorded by a rectal thermistor probe. Mean arterial blood pressure was monitored by a pressure transducer connected to the arterial catheter.
Blood flow measurements were performed as described previously according to the method of Jansson et al. (7, 8, 14, 15). Briefly, 11.5 x 105 nonradioactive microspheres (New England Nuclear Corp., Boston, MA) with a diameter of 10 µm were injected via the intracardiac catheter. Simultaneously, an arterial blood sample was withdrawn from the catheter in the abdominal aorta with a peristaltic pump adjusted to a rate of 0.6 ml/min for 90 sec. This reference sample was used to calculate the organ blood flow as described below. Then, immediately after the reference sample, 500 µl blood were quickly sampled and centrifuged, and the plasma was frozen until subsequent determinations of plasma glucose and insulin concentrations.
The rats were killed by cervical dislocation, and the pancreas and both adrenal glands were removed, blotted, and weighed. The organs and the reference sample were further processed and examined for microsphere content, as previously described. Briefly the pancreas and the adrenal glands were treated with a freeze-thawing technique that fragilizes the exocrine tissue and allows vizualization and counting of the microspheres separately in the islets and the exocrine parenchyma (6, 14, 15). The number of microspheres in the reference samples was determined by transferring the sample to glass microfiber filters and counting them in transmitted light.
Blood flow was calculated according to the following formula: Qorg = (Norg x Qref)/Nref, where Qorg is the organ blood flow (milliliters per min), Qref is the withdrawal rate of the reference sample (milliliters per min), Nref is the number of microspheres in the reference sample, and Norg is the number of microspheres in the organ.
The microsphere content of the adrenal gland was used as a measure of the mixing of microspheres with blood. A difference of more than 10% between the two adrenal glands excluded the animal from the study. Likewise, blood pressure and body temperature were continuously monitored, and variations in blood pressure or body temperature exceeding 10% and 0.5 C, respectively, led to exclusion of the animal.
In a set of experiments, rats were injected with glucose (375 mg/kg; 0.5 ml) via the left saphenous vein 5 min before blood flow measurement.
In another series of experiments, glucose (9 mg/kg; 100 µl/30 sec)
was infused into the carotid artery in a cranial direction 30 sec
before blood flow determination. Some of these rats had been injected
with clonidine (12.5 µg/kg), an
2-adrenergic agonist,
15 min previously. Other rats had been vagotomized 30 min previously.
Briefly, a laparotomy was performed, and the two branches of the vagus
along the esophagus were cut just under the diaphragm.
Plasma glucose and insulin concentrations were determined using a glucose analyzer (Glucose Analyzer 2, Beckman, Fullerton, CA) and a RIA kit (INSIK 1, CEA, Saclay, France), respectively, and were expressed as picomoles per liter and millimoles per liter, respectively.
Results are expressed as the mean ± SEM. Statistical significance of differences between means were evaluated using the Mann-Whitney U test.
| Results |
|---|
|
|
|---|
|
|
Effect of a glucose injection toward the brain
The injection toward the brain of a dose of 9 mg/kg glucose via
the carotid artery did not significantly alter the plasma glucose
concentration in C (6.3 ± 0.2 vs. 6.3 ± 0.1
mmol/liter) and HG (4.8 ± 0.2 vs. 5.1 ± 0.3
mmol/liter) rats. Insulin secretion was increased in both groups, but
this increase was larger in HG than in C rats (Fig. 2
).
Pancreatic blood flow was not significantly affected, although a slight
tendency toward an increase was present in C rats (Table 1
). In these
rats, islet blood flow was significantly increased compared to that in
the basal state, whereas this was not the case in HG rats (Fig. 2
).
However, when expressed as a percentage of the pancreatic blood flow,
islet blood flow was increased in the two groups of rats; this increase
was larger in HG than in C rats (Fig. 2
).
|
Effect of clonidine pretreatment
Compared to the basal state or after the injection of glucose, the
insulin response to a glucose load was totally blunted by pretreatment
with clonidine (Fig. 2
).
However, whereas pancreatic blood flow was not significantly altered in
HG rats, it was significantly decreased by clonidine in C rats (Table 1
). This could be due to the slight increase observed under basal
conditions in these rats (Table 1
). In contrast, islet blood flow
expressed as an absolute value or as a percentage of pancreatic blood
flow returned to the basal value in C rats after clonidine injection.
In HG rats, islet blood flow was not affected by treatment with the
2-adrenoceptor agonist (Fig. 2
).
| Discussion |
|---|
|
|
|---|
Our study shows that in response to an iv glucose load performed 24 h after the end of glucose infusion, islet blood flow was much higher in HG rats than in controls. Once again, this was concomitant with a higher glucose-induced insulin secretion. All of these data match the situation described in other models of hyperinsulinemia. Indeed, increased islet blood flow and increased plasma insulin level were observed in the basal state or after an iv glucose load in both genetic (Zucker fa/fa rat) or experimentally induced (Wistar rat after lesion of the ventromedial hypothalamus) obesity (5). Such an increase is also present in the basal state in the GK rat (18), a genetic model of type II diabetes showing postabsorptive hyperinsulinemia (21, 22).
It has been suggested that in normal rats, a change in islet blood flow after an acute glucose load could be mediated by a direct effect of the molecule on brain areas controlling the vagal cholinergic system (5, 7). Our data fit this hypothesis. Thus, glucose injection toward the brain, in an amount not sufficient to modify the systemic plasma glucose level, induced a rapid and transient increase in islet blood flow as well as in plasma insulin. This increase is much more marked in HG than in control rats. This is reminiscent of what was found in obese hyperinsulinemic fa/fa rats, in which the higher increase, compared to that in controls, in islet blood flow induced by glucose was also due at least in part to a direct effect of glucose on the brain (5, 8). Parasympathetic and sympathetic nervous systems were involved in the mediation of this effect (8). In the present study the role of the parasympathetic system was evaluated by performing a bilateral subdiaphragmatic vagotomy that abolished the effect of the glucose load on islet blood flow in both C and HG rats. The level of plasma insulin and islet blood flow in HG rats returned to that observed in C rats before glucose injection. This suggests that the effect of an acute glucose load as well as the effect of a chronic 48-h hyperglycemia are mainly mediated by the vagus nerve. This conclusion is strengthened by previous data showing that in glucose-infused rats, hyperglycemia induces increased parasympathetic activity (3), which participates in the enhanced insulinemia and islet blood flow, as previously demonstrated in obese animals (5, 8).
To investigate the possible sympathetic involvement, we used the
2-adrenergic agonist clonidine. This compound produced a
significant decrease in the plasma insulin concentration and in both
pancreatic and islet blood flow in control rats. This is in agreement
with data obtained in lean Zucker rats (8) and confirms the influence
of the sympathetic nervous system in the regulation of insulin
secretion and islet blood flow (5, 8, 23, 24, 25). In contrast, in HG rats,
although plasma insulin returned to the basal concentration, islet
blood flow was not affected by clonidine. However, its level remained
very high compared to that in C rats. These data could be interpreted
as follow. The 48-h hyperglycemia leads to a desensitization of the
regulatory system, which participates, via the sympathetic nerves, in
the control of islet blood flow, but not to that influencing insulin
secretion. The dissociation of the effects of clonidine on blood flow
and insulin secretion is not totally surprising because clonidine has
been shown to have a direct inhibitory effect on insulin secretion
in vitro (26, 27).
The association between insulin secretion and islet blood flow is controversial. Under conditions such as after starvation, a low protein diet, partial pancreatectomy, or islet grafts, the two parameters appeared to evolve independently (28, 29, 30, 31). On the contrary, in obese hyperinsulinemic rats, insulin secretion and islet blood flow seemed to be closely associated (5, 8, 11). In our own study, some data argue for an interplay between islet blood flow and insulin release. First, both were persistently increased in HG rats, at least 24 h after the end of glucose infusion. Second, there was a clear stimulation of insulin secretion and an increase in islet blood flow in response to the injection of glucose toward the brain, which were suppressed by vagotomy. However, the fact that insulin release evoked by glucose injection was free of the influence of the sympathetic nervous system, in contrast to islet blood flow, suggests that the brain areas involved in the regulation of islet blood flow and insulin secretion via the sympathetic nervous system are not exactly the same.
However, the data indicate that a 48-h hyperglycemia and/or hyperinsulinemia are sufficient to induce a perturbation in the brain areas involved in "glucose sensing" (32, 33) and, as a consequence, modify insulin secretion and islet blood flow in response to an additional acute glucose load. A change in glucose sensing, reflected in an alteration in glucose utilization in some brain areas, was also observed in conditions associated with hyperglycemia and/or hyperinsulinemia (34, 35, 36, 37).
In summary, this study demonstrates that the high islet blood flow observed in rats infused for 48 h with glucose is mainly due to the increase in parasympathetic activity, whereas the decrease in sympathetic tone does not seem to play a role. The increased parasympathetic tone is probably mediated by a direct effect of glucose on some specific brain areas.
| Footnotes |
|---|
Received October 22, 1996.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Anneren, M. Welsh, and L. Jansson Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1183 - E1190. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |